Differential gene expression during multistage carcinogenesis.
The use of the mouse skin multistage model of carcinogenesis has aided our understanding of critical target genes in chemical carcinogenesis. The mutagenic activation of the Harvey-ras proto-oncogene has been found to be an early event associated with the initiation of mouse skin tumors by the polycyclic aromatic hydrocarbon 7,12 dimethylbenz[alpha]anthracene and the pure initiator ethyl carbamate (urethane). In contrast to chemical initiation of mouse skin tumors, ionizing radiation-initiated malignant skin tumors have been shown to possess distinct non-ras transforming gene(s). Differential screening of cDNA libraries made from chemically initiated malignant skin tumors has been used to identify a number of cellular gene transcripts that are overexpressed during mouse skin tumor progression. These differentially expressed genes include beta-actin, ubiquitin, a hyperproliferative keratin (K6), a gene whose product is a member of a fatty acid or lipid-binding protein family, and a gene called transin or stromelysin. The overexpression of the stromelysin gene, which encodes a metalloproteinase that degrades proteins in the basement membrane, is hypothesized to play a functional role in malignant tumor cell invasion and metastasis. We believe that the cloning, identification, and characterization of gene sequences that are differentially expressed during tumor progression could lead to the discovery of gene products that either play functional roles in skin tumor progression or in the maintenance of various progressive tumor phenotypes.
Bowden
G T
GT
Department of Radiation Oncology, University of Arizona Medical School, Tucson 85724.
Krieg
P
P
D016475:3T3 Cells; D000818:Animals; D002273:Carcinogens; D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000235:genetics*; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000528:radiation effects; D003043:Cocarcinogenesis; D004249:DNA Damage; D004273:DNA, Neoplasm / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects / Q000528:radiation effects; D005799:Genes, Dominant; D011905:Genes, ras / Q000187:drug effects; D019278:Matrix Metalloproteinase 3; D008666:Metalloendopeptidases / Q000096:biosynthesis / Q000235:genetics; D051379:Mice; D009378:Neoplasms, Multiple Primary; D009381:Neoplasms, Radiation-Induced / Q000235:genetics; D010212:Papilloma / Q000209:etiology / Q000235:genetics*; D011519:Proto-Oncogenes / Q000187:drug effects / Q000528:radiation effects; D012878:Skin Neoplasms / Q000139:chemically induced / Q000209:etiology / Q000235:genetics*
D002273:Carcinogens; D004273:DNA, Neoplasm; D008666:Metalloendopeptidases; D019278:Matrix Metalloproteinase 3